Science Videos

from AP, Reuters, AFP, and other news services

Fresenius Medical Care Encourages Dialysis Patients to Get Flu Shots

Date:
October 8, 2013
Source:
Business Wire / Powered by NewsLook.com
Summary:
Fresenius Medical Care, the nations leading network of dialysis facilities, strongly encourages dialysis patients to get flu shots to protect themselves against this common infectious disease.


Related Videos

last updated on 2014-10-25 at 5:43 pm EDT

New Hope for Dialysis: Bioengineered Blood Vessels

New Hope for Dialysis: Bioengineered Blood Vessels

Ivanhoe (Apr. 30, 2014) — Find out how doctors are growing blood vessels to save dialysis patients without the risk of infection. Video provided by Ivanhoe
Powered by NewsLook.com
Signing Up to Get the Flu in Rare Gov't Study

Signing Up to Get the Flu in Rare Gov't Study

AP (Jan. 27, 2014) — Would you voluntarily get the flu and stay in isolation for more than a week? Groups of research participants are signing up to be part of a flu immunity study at the National Institutes of Health. (Jan. 27)
Powered by NewsLook.com
Flu Vaccine Facts

Flu Vaccine Facts

Cleveland Clinic (Oct. 13, 2014) — Chances are someone you know is at high risk of developing severe complications from the flu. Experts weigh in on why it’s important to get a flu vaccine, the type of vaccine that’s best for you, and who’s at greatest risk. Video provided by Cleveland Clinic
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins